GRAINGER DAVID J
CNTAGRAINGER DAVID J serves as Chief Innovation Officer at Centessa Pharmaceuticals plc (CNTA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
GRAINGER DAVID J's Insider Trading at Centessa Pharmaceuticals plc (CNTA)
Buys
1 · $248.8K
Sells
6 · $170.8K
Total Shares Bought
27,500
Total Shares Sold
33,347
Related Insiders
Mario Alberto Accardi
President, Orexin Program
CNTASell · Feb 1, 2026
Karen M. Anderson
Chief People Officer
CNTASell · Feb 1, 2026
Tia L Bush
Chief Technology & Quality Ofc
CNTASell · Feb 1, 2026
Gregory M Weinhoff
Chief Business Officer
CNTASell · Feb 1, 2026
HUSSAIN IQBAL J
General Counsel
CNTASell · Jan 30, 2026